Medicare Prescription Drug Lifeline Act of 2006 - Directs the Secretary of Health and Human Services to establish a process under which an individual may terminate enrollment in the prescription drug plan or the Medicare Advantage Prescription Drug (MA-PD) Plan in which he or she is enrolled and enroll in any prescription drug plan or MA-PD Plan serving the area where the individual resides that provides some coverage of covered part D (Voluntary Prescription Drug Benefit Program) drugs after the individual has reached the initial coverage limit but not yet the annual out-of-pocket threshold.
Sets forth a special rule permitting applicable individuals to enroll in a prescription drug plan outside the region in which they reside.
Directs the Comptroller General to study and report to Congress on: (1) the costs to the Medicare program of eliminating the initial coverage limit and providing specified standard prescription drug coverage until the individual reaches the annual out-of-pocket threshold; and (2) the adjustment to the applicable coinsurance that would be necessary to eliminate the initial coverage limit under such conditions without increasing the costs to the Medicare program.
[Congressional Bills 109th Congress]
[From the U.S. Government Publishing Office]
[S. 3703 Introduced in Senate (IS)]
109th CONGRESS
2d Session
S. 3703
To provide for a temporary process for individuals entering the
Medicare coverage gap to switch to a plan that provides coverage in the
gap.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
July 20, 2006
Ms. Snowe (for herself and Mr. Wyden) introduced the following bill;
which was read twice and referred to the Committee on Finance
_______________________________________________________________________
A BILL
To provide for a temporary process for individuals entering the
Medicare coverage gap to switch to a plan that provides coverage in the
gap.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Medicare Prescription Drug Lifeline
Act of 2006''.
SEC. 2. TEMPORARY PROCESS FOR INDIVIDUALS ENTERING THE MEDICARE
COVERAGE GAP TO SWITCH TO A PLAN THAT PROVIDES COVERAGE
IN THE GAP.
(a) Process.--Notwithstanding any other provision of law, by not
later than 30 days after the date of enactment of this Act, the
Secretary of Health and Human Services (in this section referred to as
the ``Secretary'') shall establish a process under which an applicable
individual may terminate enrollment in the prescription drug plan or
the MA-PD plan in which they are enrolled and enroll in any
prescription drug plan or MA-PD plan--
(1) that provides some coverage of covered part D drugs (as
defined in subsection (e) of section 1860D-2 of the Social
Security Act (42 U.S.C. 1395w-102)) after the individual has
reached the initial coverage limit under the plan but has not
reached the annual out-of-pocket threshold under subsection
(b)(4)(B) of such section; and
(2) subject to subsection (b), that serves the area in
which the individual resides.
(b) Special Rule Permitting Applicable Individuals to Enroll in a
Prescription Drug Plan Outside of the Region in Which the Individual
Resides.--In the case of an applicable individual that resides in a PDP
region under section 1860D-11(a)(2) of the Social Security Act (42
U.S.C. 1395w-111(a)(2)) in which there is no prescription drug plan
available that provides some coverage of brand name covered part D
drugs (as so defined) after the individual has reached the initial
coverage limit under the plan but before the individual has reached
such annual out-of-pocket threshold, the Secretary shall ensure that
the process established under subsection (a) permits the individual to
enroll in a prescription drug plan that provides such coverage but is
in another PDP region. The Secretary shall determine the PDP region in
which the individual may enroll in such a prescription drug plan.
(c) Notification of Applicable Individuals.--Under the process
established under subsection (a), the Secretary shall notify, or
require sponsors of prescription drug plans and organizations offering
MA-PD plans to notify, applicable individuals of the option to change
plans under such process. Such notice shall be provided to an
applicable individual within 30 days of meeting the definition of such
an individual.
(d) Process in Effect for Remaining Portion of 2006.--The process
established under subsection (a) shall remain in effect through
December 31, 2006.
(e) Definitions.--In this section:
(1) Applicable individual.--The term ``applicable
individual'' means a part D eligible individual (as defined in
section 1860D-1(a)(3)(A) of the Social Security Act (42 U.S.C.
1395w-101(a)(3)(A)) who, with respect to a year--
(A) is enrolled in a prescription drug plan or an
MA-PD plan that does not provide any coverage of
covered part D drugs (as so defined) after the
individual has reached the initial coverage limit under
the plan but has not reached such annual out-of-pocket
threshold; and
(B) has reached such initial coverage limit or is
within $750 of reaching such limit.
(2) Prescription drug plan; ma-pd plan.--The terms
``prescription drug plan'' and ``MA-PD plan'' have the meanings
given those terms in section 1860D-41(a)(14) of the Social
Security Act (42 U.S.C. 1395w-151(a)(14)) and section 1860D-
1(a)(3)(C) of such Act (42 U.S.C. 1395w-101(a)(3)(C)),
respectively.
SEC. 3. GAO STUDY AND REPORT ON THE ELIMINATION OF THE MEDICARE PART D
COVERAGE GAP.
(a) Study.--The Comptroller General of the United States shall
conduct a study on--
(1) the costs to the Medicare program of eliminating the
initial coverage limit under paragraph (3) of section 1860D-
2(b) of the Social Security Act (42 U.S.C. 1395w-102(b)) (and
providing that standard prescription drug coverage included the
coverage described in paragraph (2) of such section until the
individual reached the annual out-of-pocket threshold under
subsection (b)(4)(B) of such section); and
(2) the adjustment to the coinsurance under paragraph (2)
of such section that would be necessary to eliminate the
initial coverage limit (and provide that standard prescription
drug coverage included such adjusted coinsurance amount until
the individual reached such annual out-of-pocket threshold)
without increasing the costs to the Medicare program.
(b) Report.--Not later than May 1, 2007, the Comptroller General of
the United States shall submit a report to Congress on the study
conducted under subsection (a) together with such recommendations as
the Comptroller General determines to be appropriate.
<all>
Introduced in Senate
Sponsor introductory remarks on measure. (CR S8062-8063)
Read twice and referred to the Committee on Finance.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line